Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HpBio is a Brazilian medical device company focused on the development and manufacture of implantable and surgical products, with particular strength in neurosurgery and selected gastroenterology devices. Founded in 1985 by cardiovascular surgeon Prof. Helio Pereira de Magalhães, the company originally developed cardiac prostheses and later expanded into cerebral shunt systems, drainage systems, and intracranial pressure monitoring products. Its marketed portfolio includes hydrocephalus shunt systems under the Sphera brand, external ventricular and lumbar drainage systems, intracranial pressure and temperature monitoring catheters and monitors, and percutaneous endoscopic gastrostomy kits. HpBio emphasizes silicone-based manufacturing, international quality standards, and commercial distribution across Brazil and multiple international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HpBio Próteses.